SRC and pancreatic neoplasm: While Src mutations in human cancers are rare, increased Src expression and activity occurs in a variety of malignancies, including breast, non-small cell lung, colon, and pancreatic cancers, where it correlates with poor prognosis or mediates resistance to specific therapies5–9.